About Centrum Neurologii Krzysztof Selmaj
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
Celgene
4
Janssen Research & Development, LLC
1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
1
Clinical Trials at Centrum Neurologii Krzysztof Selmaj
During the past decade, Centrum Neurologii Krzysztof Selmaj conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on
average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-09-20
2022-12-30
Completed
835
Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients
2012-09-18
2016-05-11
Completed
258
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
2013-12-03
2017-04-13
Completed
1,320
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
2018-05-28
2026-12-04
Active, not recruiting
927
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
2018-07-12
2025-08-26
Recruiting
1,500
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Centrum Neurologii Krzysztof Selmaj
According to Clinical.Site data, the most researched conditions in "Centrum Neurologii Krzysztof Selmaj" are
"Multiple Sclerosis" (6 trials), "Relapsing Multiple Sclerosis" (6 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Myasthenia Gravis" (1 trials). Many other conditions were trialed in "Centrum Neurologii Krzysztof Selmaj" in a lesser frequency.
Clinical Trials Intervention Types at Centrum Neurologii Krzysztof Selmaj
Most popular intervention types in "Centrum Neurologii Krzysztof Selmaj" are "Drug" (17 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (8 trials), "Placebo" (5 trials), "Fenebrutinib" (3 trials), "Interferon beta-1a" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Neurologii Krzysztof Selmaj
The vast majority of trials in "Centrum Neurologii Krzysztof Selmaj" are
17 trials for "All" genders.
Clinical Trials Status at Centrum Neurologii Krzysztof Selmaj
Currently, there are NaN active trials in "Centrum Neurologii Krzysztof Selmaj".
undefined are not yet recruiting,
9 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Centrum Neurologii Krzysztof Selmaj,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Neurologii Krzysztof Selmaj, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".